1. Home
  2. Organizations
  3. Lobbying

Pharmaceutical Research & Manufacturers of America

Annual Lobbying Totals: 1998 - 2024

Bills

Bills Lobbied

more info
Bill Number Congress Title No. of Reports & Specific Issues*
H.R.5378 118 Lower Costs, More Transparency Act 8
H.R.5376 118 Share the Savings with Seniors Act 7
H.R.6283 118 DRUG Act 6
H.R.830 118 HELP Copays Act 4
S.3558 118 A bill to prohibit contracting with certain biotechnology providers, and for other purposes. 4
S.2973 118 Modernizing and Ensuring PBM Accountability Act 4
S.1339 118 Pharmacy Benefit Manager Reform Act 4
S.127 118 Pharmacy Benefit Manager Transparency Act of 2023 4
H.R.3285 118 Fairness for Patient Medications Act 3
S.150 118 Affordable Prescriptions for Patients Act of 2023 3
S.1542 118 DRUG Act 3
H.R.7085 118 BIOSECURE Act 3
H.R.7174 118 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. 3
S.113 118 Prescription Pricing for the People Act of 2023 3
H.R.2880 118 Protecting Patients Against PBM Abuses Act 3
H.R.3290 118 To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program. 3
S.142 118 Preserve Access to Affordable Generics and Biosimilars Act 2
S.2624 118 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024 2
S.2131 118 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 2
S.3430 118 Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023 2
S.1214 118 RARE Act 2
S.3583 118 A bill to address patent thickets. 2
S.79 118 Interagency Patent Coordination and Improvement Act of 2023 2
S.1067 118 Ensuring Timely Access to Generics Act of 2023 2
S.1114 118 Expanding Access to Low-Cost Generics Act of 2023 2
S.1906 118 Promising Pathway Act 2
S.2333 118 Pandemic and All-Hazards Preparedness and Response Act 2
S.2226 118 National Defense Authorization Act for Fiscal Year 2024 2
S.1967 118 PBM Act 2
H.R.3858 118 No Free TRIPS Act 2
H.R.6664 118 Innovation in Pediatric Drugs Act of 2023 2
S.1264 118 SMART Prices Act 2
H.R.2666 118 MVP Act 2
H.R.3433 118 Give Kids a Chance Act of 2023 2
H.R.2670 118 National Defense Authorization Act for Fiscal Year 2024 2
H.R.5894 118 Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes. 2
S.148 118 Stop STALLING Act 2
S.2305 118 A bill to improve the requirements for making a determination of interchangeability of a biological product and its reference product. 2
H.R.2679 118 Pharmacy Benefits Manager Accountability Act 2
H.R.4368 118 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 2
H.R.485 118 Protecting Health Care for All Patients Act of 2023 1
H.R.4895 118 Lowering Drug Costs for American Families Act 1
H.R.5391 118 Protecting Patient Access to Cancer and Complex Therapies Act 1
H.R.885 118 TRACK Act of 2023 1
H.R.3008 118 Drug Shortage Prevention Act of 2023 1
H.R.3421 118 Medicare for All Act 1
H.R.4366 118 Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2024 1
S.2840 118 Bipartisan Primary Care and Health Workforce Act 1
S.935 118 Fair Accountability and Innovative Research Drug Pricing Act of 2023 1
H.R.2500 118 Protecting Americans from Unsafe Drugs Act of 2023 1
S.1834 118 No Free TRIPS Act 1
H.R.133 118 Mandating Exclusive Review of Individual Treatments (MERIT) Act 1
H.R.1790 118 Biologics Competition Act of 2023 1
H.R.2408 118 Access to Innovative Treatments Act of 2023 1
S.2140 118 Patent Eligibility Restoration Act of 2023 1
S.2780 118 Medication Affordability and Patent Integrity Act 1
S.775 118 Increasing Transparency in Generic Drug Applications Act 1
H.R.1717 118 Interagency Patent Coordination and Improvement Act of 2023 1
H.R.6436 118 Stopping Pharma’s Ripoffs and Drug Savings For All Act 1
H.R.4692 118 Increasing Prescription Drug Competition Act 1
H.R.5475 118 Prohibiting Adversarial Patents Act of 2023 1
H.R.3839 118 To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. 1
H.R.4115 118 Lower Drug Costs for Families Act 1
H.R.4822 118 Health Care Price Transparency Act of 2023 1
S.1476 118 Pharmaceutical Research Transparency Act of 2023 1
S.1355 118 PASTEUR Act of 2023 1
H.R.405 118 Essential Medicines Strategic Stockpile Act of 2023 1
H.R.4307 118 Medical Supply Chain Resiliency Act 1
H.R.4421 118 To reauthorize certain programs under the Public Health Service Act with respect to public health security and all-hazards preparedness and response related to the Administration for Strategic Preparedness and Response, and for other purposes. 1
H.R.5429 118 Medication Affordability and Patent Integrity Act 1
H.R.5547 118 Maintaining Investments in New Innovation Act 1
H.R.6986 118 To address patent thickets. 1
H.R.7248 118 FDA Modernization Act 3.0 1
H.R.2959 118 Health Savings Act of 2023 1
H.R.3093 118 Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2023 1
H.R.3746 118 Fiscal Responsibility Act of 2023 1
H.R.5539 118 ORPHAN Cures Act 1
H.R.6275 118 Protecting Consumer Access to Generic Drugs Act of 2023 1
H.R.6684 118 Improving Efficiency to Increase Competition Act 1
S.1128 118 Ensuring Access to Generic Medications Act 1
S.2474 118 Share the Savings with Seniors Act 1
H.R.2816 118 Pharmacy Benefit Manager Sunshine and Accountability Act 1
H.R.1503 118 Prescription Information Modernization Act of 2023 1
H.R.1613 118 Drug Price Transparency in Medicaid Act of 2023 1
H.R.2707 118 MADE in America Act 1
H.R.2893 118 Seniors Securing Access to Vital and Essential Prescription Drugs Act 1
S.2897 118 Give Kids a Chance Act of 2023 1
S.3393 118 SUPPORT for Patients and Communities Reauthorization Act 1
S.2115 118 Medical Supply Chain Resiliency Act 1
S.2220 118 A bill to amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes. 1
S.1130 118 Health Care PRICE Transparency Act 1
S.1375 118 HELP Copays Act 1
S.1497 118 Emergency Access to Insulin Act of 2023 1
S.1250 118 Drug-price Transparency for Consumers Act of 2023 1
S.1589 118 Safeguarding Patients and Taxpayers Act 1
S.1450 118 Cutting Medicare Prescription Drug Prices in Half Act 1
S.845 118 Short on Competition Act 1
H.R.2534 118 PROTECT 340B Act of 2023 1
H.R.2882 118 Udall Foundation Reauthorization Act of 2023 1
H.R.4263 118 ADINA Act 1
H.R.456 118 Fairness in Orphan Drug Exclusivity Act 1
H.R.4988 118 Modern Authentication of Pharmaceuticals Act of 2023 1
S.2456 118 A bill to amend title XVIII of the Social Security Act to limit beneficiary cost-sharing to the net price of covered part D drugs. 1
S.1209 118 Tax Refund Protection Act 1
S.574 118 Increasing Prescription Drug Competition Act 1
S.954 118 Affordable Insulin Now Act of 2023 1
H.R.167 118 Patient Access to Urgent-Use Pharmacy Compounding Act of 2023 1
H.R.198 118 Drug Pricing Transparency and Accountability Act 1
H.R.3561 118 PATIENT Act of 2023 1
H.R.4370 118 To amend title 35, United States Code, to invest in inventors in the United States, maintain the United States as the leading innovation economy in the world, and protect the property rights of the inventors that grow the economy of the United States, and for other purposes. 1
H.R.4408 118 To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes. 1
*Each quarterly filing is treated as a separate report.

Feel free to distribute or cite this material, but please credit OpenSecrets. For permission to reprint for commercial uses, such as textbooks, contact OpenSecrets: [email protected]